2 Hot Stocks to Watch: Ocular Therapeutix, Inc. (NASDAQ:OCUL), Stemline Therapeutics, Inc. (NASDAQ:STML)

Ocular Therapeutix, Inc. (NASDAQ:OCUL)

The shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) started off the last trading session with the price of $6.46 while closing the day with the price of $7.08. The shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Rise 9.94% with the Gain of 0.62 points.

The shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) traded with the day volume of 1.85 Million shares whereas its average trading volume is 487.71 Million.

While analyzing the past performance of the stock we can see that the shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Gain 20% in the last week while rising 43.32% in the last month. Past quarter performance shows the green light with 50.96%. The semi-annual and annual performance shows 10.11% and -29.06% respectively.

Some critical values of the shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) to be discussed here are: the beta which shows the value at 1.47 while Average True Range of Ocular Therapeutix, Inc. (NASDAQ:OCUL) demonstrate the value at 0.39. The weekly and monthly volatility of the shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) are indicated at 7.14% and 6.90%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 73.9.

While studying the financial position of the shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL), we can see that the Market capitalization of the company is at 232.93 Million. The shares outstanding for the company is 32.9 Million and the shares float stands at 32.73 Million. The income of the company stand at -63100000 while the sales stand at 1.9 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -2.27, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 122.6, the Return on Asset ROA stood at -0.874 and the Return on Equity ROE depicted at -1.457 while Return on Investment ROI is at -1.404.


Stemline Therapeutics, Inc. (NASDAQ:STML)

Stemline Therapeutics, Inc. (NASDAQ:STML) started its previous trading session at $14.55 and closed at $14.05 showing a Fell of -6.33 Percent.

The Company traded with an average Volume of 288.26 Million whereas, its Day Volume stood at 2.01 Million.

Looking at the performance of the stock, Stemline Therapeutics, Inc. (NASDAQ:STML) Loss -24.05% in the last week in its shares price and -11.36% in the last month. Quarterly performance shows a red of -10.22 Percent while Semi-Annual and Annual performances shows a 39.8 and 38.42 percent respectively.

Beta for Stemline Therapeutics, Inc. (NASDAQ:STML) stands at -0.04 while the ATR (average true range) is at 1.12. The Stock’s Weekly and Monthly Volatility is 9.51% and 6.56% respectively showing a RSI value of 35.51.

While studying the financial position of the shares of Stemline Therapeutics, Inc. (NASDAQ:STML), we can see that the Market capitalization of the company is at 434.57 Million. The shares outstanding for the company is 30.93 Million and the shares float stands at 25.51 Million.

The Company generated an income of -56100000 and the sales of 1.2 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.57 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 362.14 respectively.

The Return on Assets stands at -0.572, ROE shows a value of -0.672 and ROI for Stemline Therapeutics, Inc. (NASDAQ:STML) is -0.673 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment